Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Obesity 1Neoplasms, Squamous Cell 1Neoplasms 1Motor Activity 1Head and Neck Neoplasms 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Cetuximab 6Cisplatin 4pembrolizumab 3Fluorouracil 3zalutumumab 2Paclitaxel 2Nivolumab 2Gefitinib 2temsirolimus 1sintilimab 1osimertinib 1cobimetinib 1Vorinostat 1Sorafenib 1Risk Factors 1Ribavirin 1Radiotherapy 1Proflavine 1Pemetrexed 1Jogging 1Imatinib Mesylate 1Docetaxel 1Dexamethasone 1Cyclophosphamide 1Cilengitide 1Carboplatin 1Calcium Dobesilate 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Squamous Cell × Jogging × Clear all
NCT01721525 2017-10-25

Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡